FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Helio Sader

Research Profile

Procedures

Chemicals & Drugs

Physiology

Living Beings

Geographic Areas

Disorders

Gram-Positive Bacterial Infections

Co-author Network

Publications

TOP 3
Rodrigo E Mendes; Helio S Sader; M R K Alley; Douglas J Biedenbach; Ronald N Jones
Potency and Spectrum of Activity of AN3365, a Novel Boron-Containing Protein Synthesis Inhibitor, Tested against Clinical Isolates of Enterobacteriaceae and Nonfermentative Gram-Negative Bacilli.
Helio S Sader; Robert K Flamm; Ronald N Jones
Antimicrobial activity of ceftaroline and comparator agents tested against bacterial isolates causing skin and soft tissue infections and community-acquired respiratory tract infections isolated from the Asia-Pacific region and South Africa (2010).
Ronald N Jones; Helio S Sader; Robert K Flamm; Amy A Watters
More potency assay results for generic non-USA lots of piperacillin/tazobactam and initial reports for generic meropenem compounds marketed in the USA.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Helio Sader (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Rodrigo E Mendes; Helio S Sader; M R K Alley; Douglas J Biedenbach; Ronald N Jones
Potency and Spectrum of Activity of AN3365, a Novel Boron-Containing Protein Synthesis Inhibitor, Tested against Clinical Isolates of Enterobacteriaceae and Nonfermentative Gram-Negative Bacilli.
Antimicrobial agents and chemotherapy 2013;57(6):2849-57.
2013: Helio S Sader; Robert K Flamm; Ronald N Jones
Antimicrobial activity of ceftaroline and comparator agents tested against bacterial isolates causing skin and soft tissue infections and community-acquired respiratory tract infections isolated from the Asia-Pacific region and South Africa (2010).
Diagnostic microbiology and infectious disease 2013;76(1):61-8.
2013: Ronald N Jones; Helio S Sader; Robert K Flamm; Amy A Watters
More potency assay results for generic non-USA lots of piperacillin/tazobactam and initial reports for generic meropenem compounds marketed in the USA.
Diagnostic microbiology and infectious disease 2013;76(1):110-2.
2013: Ronald N Jones; Robert K Flamm; Helio S Sader
Surveillance of dalbavancin potency and spectrum in the United States (2012).
Diagnostic microbiology and infectious disease 2013;76(1):122-3.
2013: Helio S Sader; Robert K Flamm; Ronald N Jones
Antimicrobial activity of daptomycin tested against Gram-positive pathogens collected in Europe, Latin America, and selected countries in the Asia-Pacific Region (2011).
Diagnostic microbiology and infectious disease 2013;75(4):417-22.
2013: Ronald N Jones; Paul R Rhomberg; James E Ross; Helio S Sader; Robert K Flamm; Teri Glick; Daniel C Edson
Educational antimicrobial susceptibility testing as a critical component of microbiology laboratory proficiency programs: American Proficiency Institute results for 2007-2011.
Diagnostic microbiology and infectious disease 2013;75(4):357-60.
2013: David J Farrell; Robert K Flamm; Helio S Sader; Ronald N Jones
Spectrum and potency of ceftaroline tested against leading pathogens causing skin and soft-tissue infections in Europe (2010).
International journal of antimicrobial agents 2013;41(4):337-42.
2013: Helio S Sader; Robert K Flamm; Ronald N Jones
Antimicrobial activity of ceftaroline-avibactam tested against clinical isolates collected from U.S. Medical Centers in 2010-2011.
Antimicrobial agents and chemotherapy 2013;57(4):1982-8.
2013: Ronald N Jones; Helio S Sader; Robert K Flamm
Update of dalbavancin spectrum and potency in the USA: report from the SENTRY Antimicrobial Surveillance Program (2011).
Diagnostic microbiology and infectious disease 2013;75(3):304-7.
2013: Martti Vaara; Ronald N Jones; Paul R Rhomberg; Helio S Sader; Timo Vaara
Antimicrobial activity of the novel polymyxin derivative NAB739 tested against Gram-negative pathogens.
The Journal of antimicrobial chemotherapy 2013;68(3):636-9.
2013: Robert K Flamm; Rodrigo E Mendes; James E Ross; Helio S Sader; Ronald N Jones
Linezolid surveillance results for the United States: LEADER surveillance program 2011.
Antimicrobial agents and chemotherapy 2013;57(2):1077-81.
2013: David J Farrell; Robert K Flamm; Ronald N Jones; Helio S Sader
Spectrum and potency of ceftaroline tested against leading pathogens causing community-acquired respiratory tract infections in Europe (2010).
Diagnostic microbiology and infectious disease 2013;75(1):86-8.
2013: Ronald N Jones; Helio S Sader; Robert K Flamm; Matthew G Stilwell
Interim susceptibility testing for ceftaroline, a new MRSA-active cephalosporin: selecting potent surrogate β-lactam markers to predict ceftaroline activity against clinically indicated species.
Diagnostic microbiology and infectious disease 2013;75(1):89-93.
2013: Ronald N Jones; Rodrigo E Mendes; Helio S Sader; Robert K Flamm
Update on antimicrobial susceptibility trends among Streptococcus pneumoniae in the United States: report of ceftaroline activity from the SENTRY Antimicrobial Surveillance Program (1998-2011).
Diagnostic microbiology and infectious disease 2013;75(1):107-9.
2012: Robert K Flamm; Rodrigo E Mendes; James E Ross; Helio S Sader; David J Farrell; Ronald N Jones
ZAAPS Program results for 2010: an activity and spectrum analysis of linezolid using clinical isolates from 75 medical centres in 24 countries.
Journal of chemotherapy (Florence, Italy) 2012;24(6):328-37.
2012: Helio S Sader; Paul R Rhomberg; Robert K Flamm; Ronald N Jones
Use of a surfactant (polysorbate 80) to improve MIC susceptibility testing results for polymyxin B and colistin.
Diagnostic microbiology and infectious disease 2012;74(4):412-4.
2012: Robert K Flamm; David J Farrell; Helio S Sader; Ronald N Jones
Macrolide and tetracycline resistance among Moraxella catarrhalis isolates from 2009 to 2011.
Diagnostic microbiology and infectious disease 2012;74(2):198-200.
2012: James E Ross; Helio S Sader; Zrinka Ivezic-Schoenfeld; Susanne Paukner; Ronald N Jones
Disk diffusion and MIC quality control ranges for BC-3205 and BC-3781, two novel pleuromutilin antibiotics.
Journal of clinical microbiology 2012;50(10):3361-4.
2012: David J Farrell; Rodrigo E Mendes; Helio S Sader; Mariana Castanheira; Ronald N Jones
In vitro activity of ceftaroline against multidrug-resistant Staphylococcus aureus and Streptococcus pneumoniae: a review of published studies and the AWARE Surveillance Program (2008-2010).
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2012;55 Suppl 3():S206-14.
2012: Robert K Flamm; David J Farrell; Helio S Sader; Ronald N Jones
Ceftaroline potency among 9 US Census regions: report from the 2010 AWARE Program.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2012;55 Suppl 3():S194-205.
2012: Michael A Pfaller; Helio S Sader; David J Farrell; Ronald N Jones
AWARE Ceftaroline Surveillance Program (2008-2010): trends in resistance patterns among Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2012;55 Suppl 3():S187-93.
2012: Helio S Sader; David J Farrell; Robert K Flamm; Ronald N Jones
Activity analyses of staphylococcal isolates from pediatric, adult, and elderly patients: AWARE Ceftaroline Surveillance Program.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2012;55 Suppl 3():S181-6.
2012: Mariana Castanheira; David J Farrell; Rodrigo E Mendes; Helio S Sader; Ronald N Jones
Activity of ceftaroline-avibactam tested against Gram-negative organism populations, including strains expressing one or more β-lactamases and methicillin-resistant Staphylococcus aureus carrying various staphylococcal cassette chromosome mec types.
Antimicrobial agents and chemotherapy 2012;56(9):4779-85.
2012: Robert K Flamm; Rodrigo E Mendes; James E Ross; Helio S Sader; David J Farrell; Ronald N Jones
LEADER surveillance program results for 2010: an activity and spectrum analysis of linezolid using 6801 clinical isolates from the United States (61 medical centers).
Diagnostic microbiology and infectious disease 2012;74(1):54-61.
2012: Rodrigo E Mendes; Helio S Sader; David J Farrell; Ronald N Jones
Worldwide appraisal and update (2010) of telavancin activity tested against a collection of Gram-positive clinical pathogens from five continents.
Antimicrobial agents and chemotherapy 2012;56(7):3999-4004.
2012: Helio S Sader; Ronald N Jones
Antimicrobial activity of daptomycin in comparison to glycopeptides and other antimicrobials when tested against numerous species of coagulase-negative Staphylococcus.
Diagnostic microbiology and infectious disease 2012;73(2):212-4.
2012: Robert K Flamm; David J Farrell; Helio S Sader; Ronald N Jones
Summary of ceftaroline activity against pathogens in the United States, 2010: report from the Assessing Worldwide Antimicrobial Resistance Evaluation (AWARE) surveillance program.
Antimicrobial agents and chemotherapy 2012;56(6):2933-40.
2012: Rodrigo E Mendes; Helio S Sader; Athanassios Tsakris; Pamela McGhee; Peter C Appelbaum; Donald Biek; Ronald N Jones; Klaudia Kosowska-Shick
Characterization of methicillin-resistant Staphylococcus aureus displaying increased MICs of ceftaroline.
The Journal of antimicrobial chemotherapy 2012;67(6):1321-4.
2012: Helio S Sader; Franz J Schmitz; Douglas J Biedenbach; Zrinka Ivezic-Schoenfeld; Susanne Paukner; Ronald N Jones
Antimicrobial activity of the novel pleuromutilin antibiotic BC-3781 against organisms responsible for community-acquired respiratory tract infections (CARTIs).
The Journal of antimicrobial chemotherapy 2012;67(5):1170-5.
2012: Rodrigo E Mendes; Helio S Sader; David J Farrell; Ronald N Jones
Oritavancin microbiologic features and activity results from the surveillance program in the United States.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2012;54 Suppl 3():S203-13.
2012: Helio S Sader; Susanne Paukner; Douglas J Biedenbach; Zrinka Ivezic-Schoenfeld; Ronald N Jones
Antimicrobial activity of the investigational pleuromutilin compound BC-3781 tested against Gram-positive organisms commonly associated with acute bacterial skin and skin structure infections.
Antimicrobial agents and chemotherapy 2012;56(3):1619-23.
2012: Rodrigo E Mendes; Helio S Sader; Leah N Woosley; David J Farrell; Ronald N Jones
Oritavancin activity against vancomycin-susceptible and vancomycin-resistant Enterococci with molecularly characterized glycopeptide resistance genes recovered from bacteremic patients, 2009-2010.
Antimicrobial agents and chemotherapy 2012;56(3):1639-42.
2012: Rayo Morfin-Otero; Hector Raul Perez-Gomez; Luis Petersen; Helio S Sader; Lorena Salcido-Gutierrez; Juan Carlos Tinoco-Favila; Esteban Gonzalez-Diaz; Eduardo Rodriguez-Noriega
Resistance trends in gram-negative bacteria: surveillance results from two Mexican hospitals, 2005-2010.
BMC research notes 2012;5():277.
2011: James E Ross; Helio S Sader; Nicole E Scangarella-Oman; Linda A Miller; Ronald N Jones
Determination of disk diffusion and MIC quality control ranges for GSK1322322, a novel peptide deformylase inhibitor.
Journal of clinical microbiology 2011;49(11):3928-30.
2011: Rodrigo E Mendes; Helio S Sader; Tara C Smith; Lalitagauri Deshpande; Daniel J Diekema; Ronald N Jones
Plasmid-borne vga(A)-encoding gene in methicillin-resistant Staphylococcus aureus ST398 recovered from swine and a swine farmer in the United States.
Diagnostic microbiology and infectious disease 2011;71(2):177-80.
2011: Rodrigo E Mendes; Helio S Sader; David J Farrell; Ronald N Jones
Update on the telavancin activity tested against European staphylococcal clinical isolates (2009-2010).
Diagnostic microbiology and infectious disease 2011;71(1):93-7.
2011: Helio S Sader; Gary J Moet; David J Farrell; RN Jones
Antimicrobial susceptibility of daptomycin and comparator agents tested against methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: trend analysis of a 6-year period in US medical centers (2005-2010).
Diagnostic microbiology and infectious disease 2011;70(3):412-6.
2011: Ronald N Jones; Rodrigo E Mendes; Helio S Sader; Mariana Castanheira
In vitro antimicrobial findings for fusidic acid tested against contemporary (2008-2009) gram-positive organisms collected in the United States.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2011;52 Suppl 7():S477-86.
2011: Ronald N Jones; David J Farrell; Helio S Sader
Comparative activity of linezolid against respiratory tract infection isolates of Staphylococcus aureus: an 11-year report from the SENTRY Antimicrobial Surveillance Program.
International journal of antimicrobial agents 2011;37(6):584-5.
2011: Helio S Sader; Paul R Rhomberg; David J Farrell; Ronald N Jones
Antimicrobial activity of CXA-101, a novel cephalosporin tested in combination with tazobactam against Enterobacteriaceae, Pseudomonas aeruginosa, and Bacteroides fragilis strains having various resistance phenotypes.
Antimicrobial agents and chemotherapy 2011;55(5):2390-4.
2011: Ronald N Jones; David J Farrell; Rodrigo E Mendes; Helio S Sader
Comparative ceftaroline activity tested against pathogens associated with community-acquired pneumonia: results from an international surveillance study.
The Journal of antimicrobial chemotherapy 2011;66 Suppl 3():iii69-80.
2011: Helio S Sader; David J Farrell; Ronald N Jones
Tigecycline activity tested against multidrug-resistant Enterobacteriaceae and Acinetobacter spp. isolated in US medical centers (2005-2009).
Diagnostic microbiology and infectious disease 2011;69(2):223-7.
2011: Helio S Sader; David J Farrell; Ronald N Jones
Susceptibility of Klebsiella spp. to colistin and polymyxin B: results from the SENTRY Antimicrobial Surveillance Program (2006-2009).
International journal of antimicrobial agents 2011;37(2):174-5.
2011: Shan Putnam; Helio S Sader; David J Farrell; Douglas J Biedenbach; Mariana Castanheira
Antimicrobial characterisation of solithromycin (CEM-101), a novel fluoroketolide: activity against staphylococci and enterococci.
International journal of antimicrobial agents 2011;37(1):39-45.
2010: David J Farrell; Mariana Castanheira; Helio S Sader; Ronald N Jones
The in vitro evaluation of solithromycin (CEM-101) against pathogens isolated in the United States and Europe (2009).
The Journal of infection 2010;61(6):476-83.
2010: Ronald N Jones; Rodrigo E Mendes; Helio S Sader
Ceftaroline activity against pathogens associated with complicated skin and skin structure infections: results from an international surveillance study.
The Journal of antimicrobial chemotherapy 2010;65 Suppl 4():iv17-31.
2010: Ronald N Jones; Helio S Sader; Gary J Moet; David J Farrell
Declining antimicrobial susceptibility of Streptococcus pneumoniae in the United States: report from the SENTRY Antimicrobial Surveillance Program (1998-2009).
Diagnostic microbiology and infectious disease 2010;68(3):334-6.
2010: Rodrigo E Mendes; David J Farrell; Helio S Sader; Ronald N Jones
Comprehensive assessment of tigecycline activity tested against a worldwide collection of Acinetobacter spp. (2005-2009).
Diagnostic microbiology and infectious disease 2010;68(3):307-11.
2010: Michael A Pfaller; Rodrigo E Mendes; Helio S Sader; Ronald N Jones
Telavancin activity against Gram-positive bacteria isolated from respiratory tract specimens of patients with nosocomial pneumonia.
The Journal of antimicrobial chemotherapy 2010;65(11):2396-404.
2010: Rodrigo E Mendes; Helio S Sader; Ronald N Jones
Activity of telavancin and comparator antimicrobial agents tested against Staphylococcus spp. isolated from hospitalised patients in Europe (2007-2008).
International journal of antimicrobial agents 2010;36(4):374-9.
2010: Ronald N Jones; Michael R Jacobs; Helio S Sader
Evolving trends in Streptococcus pneumoniae resistance: implications for therapy of community-acquired bacterial pneumonia.
International journal of antimicrobial agents 2010;36(3):197-204.
2010: Shan Putnam; Helio S Sader; Gary J Moet; Rodrigo E Mendes; Ronald N Jones
Worldwide summary of telavancin spectrum and potency against Gram-positive pathogens: 2007 to 2008 surveillance results.
Diagnostic microbiology and infectious disease 2010;67(4):359-68.
2010: Helio S Sader; David J Farrell; Ronald N Jones
Antimicrobial susceptibility of Gram-positive cocci isolated from skin and skin-structure infections in European medical centres.
International journal of antimicrobial agents 2010;36(1):28-32.
2010: David J Farrell; Helio S Sader; Ronald N Jones
Antimicrobial susceptibilities of a worldwide collection of Stenotrophomonas maltophilia isolates tested against tigecycline and agents commonly used for S. maltophilia infections.
Antimicrobial agents and chemotherapy 2010;54(6):2735-7.
2010: David J Farrell; John D Turnidge; Jan Bell; Helio S Sader; RN Jones
The in vitro evaluation of tigecycline tested against pathogens isolated in eight countries in the Asia-Western Pacific region (2008).
The Journal of infection 2010;60(6):440-51.
2010: Michael R Jacobs; Caryn E Good; Anne Windau; Saralee Bajaksouzian; Donald Biek; Ian A Critchley; Helio S Sader; Ronald N Jones
Activity of ceftaroline against recent emerging serotypes of Streptococcus pneumoniae in the United States.
Antimicrobial agents and chemotherapy 2010;54(6):2716-9.
2010: David J Farrell; Helio S Sader; Mariana Castanheira; Douglas J Biedenbach; Paul R Rhomberg; Ronald N Jones
Antimicrobial characterisation of CEM-101 activity against respiratory tract pathogens, including multidrug-resistant pneumococcal serogroup 19A isolates.
International journal of antimicrobial agents 2010;35(6):537-43.
2010: Mariana Castanheira; Helio S Sader; Ronald N Jones
Antimicrobial susceptibility patterns of KPC-producing or CTX-M-producing Enterobacteriaceae.
Microbial drug resistance (Larchmont, N.Y.) 2010;16(1):61-5.
2010: Helio S Sader; Holly K Becker; Gary J Moet; Ronald N Jones
Antimicrobial activity of daptomycin tested against Staphylococcus aureus with vancomycin MIC of 2 microg/mL isolated in the United States and European hospitals (2006-2008).
Diagnostic microbiology and infectious disease 2010;66(3):329-31.
2010: Michael A Pfaller; Mariana Castanheira; Helio S Sader; Ronald N Jones
Evaluation of the activity of fusidic acid tested against contemporary Gram-positive clinical isolates from the USA and Canada.
International journal of antimicrobial agents 2010;35(3):282-7.
2010: Rodrigo E Mendes; Helio S Sader; Lalitagauri M Deshpande; Binh An Diep; Henry F Chambers; Ronald N Jones
Characterization of baseline methicillin-resistant Staphylococcus aureus isolates recovered from phase IV clinical trial for linezolid.
Journal of clinical microbiology 2010;48(2):568-74.
2010: Jan M Bell; John D Turnidge; Helio S Sader; Ronald N Jones
Antimicrobial activity and spectrum of daptomycin: results from the surveillance program in Australia and New Zealand (2008).
Pathology 2010;42(5):470-3.
2009: Ronald N Jones; Matthew G Stilwell; Paul R Rhomberg; Helio S Sader
Antipseudomonal activity of piperacillin/tazobactam: more than a decade of experience from the SENTRY Antimicrobial Surveillance Program (1997-2007).
Diagnostic microbiology and infectious disease 2009;65(3):331-4.
2009: Gary J Moet; Amy A Watters; Helio S Sader; Ronald N Jones
Expanded studies of piperacillin/tazobactam formulations: variations among branded product lots and assessment of 46 generic lots.
Diagnostic microbiology and infectious disease 2009;65(3):319-22.
2009: Helio S Sader; Ronald N Jones; Kerri L Rossi; Michael J Rybak
Occurrence of vancomycin-tolerant and heterogeneous vancomycin-intermediate strains (hVISA) among Staphylococcus aureus causing bloodstream infections in nine USA hospitals.
The Journal of antimicrobial chemotherapy 2009;64(5):1024-8.
2009: Dilip Mathai; Douglas J Biedenbach; Ronald N Jones; Jan M Bell; John Turnidge; Helio S Sader
Activity of daptomycin against gram-positive bacterial isolates from Indian medical centres (2006-2007).
International journal of antimicrobial agents 2009;34(5):497-9.
2009: Helio S Sader; Ronald N Jones
Antimicrobial susceptibility of Gram-positive bacteria isolated from US medical centers: results of the Daptomycin Surveillance Program (2007-2008).
Diagnostic microbiology and infectious disease 2009;65(2):158-62.
2009: Helio S Sader; Paul D Fey; Ajit P Limaye; Nancy Madinger; Douglas N Fish; George Pankey; James Rahal; Michael J Rybak; David R Snydman; Lisa L Steed; Ken Waites; Ronald N Jones
Evaluation of vancomycin and daptomycin potency trends (MIC creep) against methicillin-resistant Staphylococcus aureus isolates collected in nine U.S. medical centers from 2002 to 2006.
Antimicrobial agents and chemotherapy 2009;53(10):4127-32.
2009: Helio S Sader; Paul R Rhomberg; Ronald N Jones
Nine-hospital study comparing broth microdilution and Etest method results for vancomycin and daptomycin against methicillin-resistant Staphylococcus aureus.
Antimicrobial agents and chemotherapy 2009;53(7):3162-5.
2009: Jana M Swenson; William B Brasso; Mary Jane Ferraro; Dwight J Hardy; Cynthia C Knapp; David Lonsway; Sigrid McAllister; L Barth Reller; Helio S Sader; Dee Shortridge; Robert Skov; Melvin P Weinstein; Barbara L Zimmer; Jean B Patel
Correlation of cefoxitin MICs with the presence of mecA in Staphylococcus spp.
Journal of clinical microbiology 2009;47(6):1902-5.
2009: Céline Vidaillac; Steve N Leonard; Helio S Sader; Ronald N Jones; Michael J Rybak
In vitro activity of ceftaroline alone and in combination against clinical isolates of resistant gram-negative pathogens, including beta-lactamase-producing Enterobacteriaceae and Pseudomonas aeruginosa.
Antimicrobial agents and chemotherapy 2009;53(6):2360-6.
2009: Helio S Sader; Thomas R Fritsche; Ronald N Jones
Potency and bactericidal activity of iclaprim against recent clinical gram-positive isolates.
Antimicrobial agents and chemotherapy 2009;53(5):2171-5.
2009: Ana Gales; Helio S Sader; Julival Ribeiro; CM Zoccoli; Afonso Barth; A C C Pignatari
Antimicrobial susceptibility of gram-positive bacteria isolated in Brazilian hospitals participating in the SENTRY Program (2005-2008).
The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases 2009;13(2):90-8.
2009: Thomas R Fritsche; Helio S Sader; Matthew G Stillwell; Ronald N Jones
Antimicrobial activity of doripenem tested against prevalent Gram-positive pathogens: results from a global surveillance study (2003-2007).
Diagnostic microbiology and infectious disease 2009;63(4):440-6.
2009: Ronald N Jones; Jan M Bell; Helio S Sader; John D Turnidge; Matthew G Stilwell
In vitro potency of doripenem tested against an international collection of rarely isolated bacterial pathogens.
Diagnostic microbiology and infectious disease 2009;63(4):434-9.
2009: Rodrigo E Mendes; Paul R Rhomberg; Jan M Bell; John D Turnidge; Helio S Sader
Doripenem activity tested against a global collection of Enterobacteriaceae, including isolates resistant to other extended-spectrum agents.
Diagnostic microbiology and infectious disease 2009;63(4):415-25.
2009: Ronald N Jones; Gary J Moet; Helio S Sader; Rodrigo E Mendes; Mariana Castanheira
TR-700 in vitro activity against and resistance mutation frequencies among Gram-positive pathogens.
The Journal of antimicrobial chemotherapy 2009;63(4):716-20.
2009: Rayo Morfin-Otero; Eduardo Rodriguez-Noriega; Lalitagauri M Deshpande; Helio S Sader; Mariana Castanheira
Dissemination of a bla(VIM-2)-carrying integron among Enterobacteriaceae species in Mexico: report from the SENTRY Antimicrobial Surveillance Program.
Microbial drug resistance (Larchmont, N.Y.) 2009;15(1):33-5.
2009: Ronald N Jones; Douglas J Biedenbach; Helio S Sader
In vitro activity of iclaprim and comparison agents tested against Neisseria gonorrhoeae including medium growth supplement effects.
Diagnostic microbiology and infectious disease 2009;63(3):339-41.
2009: Douglas J Biedenbach; Jan M Bell; Helio S Sader; John D Turnidge; Ronald N Jones
Activities of dalbavancin against a worldwide collection of 81,673 gram-positive bacterial isolates.
Antimicrobial agents and chemotherapy 2009;53(3):1260-3.
2009: Helio S Sader; Thomas R Fritsche; Ronald N Jones
Antimicrobial activity of daptomycin and selected comparators tested against bloodstream Staphylococcus aureus isolates from hemodialysis patients.
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2009;13(2):291-5.
2008: Helio S Sader; Laura M Koeth; James A Poupard; Ronald N Jones
Interpretive categorical accuracy of fluoroquinolone reference broth microdilution MIC results when testing Streptococcus pneumoniae: selection of a surrogate testing agent.
Diagnostic microbiology and infectious disease 2008;62(4):460-3.
2008: Ronald Jones; Thomas R Fritsche; Helio S Sader
Antimicrobial activity of DC-159a, a new fluoroquinolone, against 1,149 recently collected clinical isolates.
Antimicrobial agents and chemotherapy 2008;52(10):3763-75.
2008: U Garza-Ramos; R Morfin-Otero; Helio S Sader; Ronald N Jones; E Hernández; E Rodriguez-Noriega; A Sanchez; B Carrillo; S Esparza-Ahumada; J Silva-Sanchez
Metallo-beta-lactamase gene bla(IMP-15) in a class 1 integron, In95, from Pseudomonas aeruginosa clinical isolates from a hospital in Mexico.
Antimicrobial agents and chemotherapy 2008;52(8):2943-6.
2008: Craig A Martin; Kazumi Morita; Julie A Ribes; Lalitagauri M Deshpande; Helio S Sader; Mariana Castanheira
IMP-15-producing Pseudomonas aeruginosa strain isolated in a U.S. medical center: a recent arrival from Mexico.
Antimicrobial agents and chemotherapy 2008;52(6):2289-90.
2008: Mariana Castanheira; Ronald Jones; Helio S Sader
Update of the in vitro activity of daptomycin tested against 6710 Gram-positive cocci isolated in North America (2006).
Diagnostic microbiology and infectious disease 2008;61(2):235-9.
2008: Thomas R Fritsche; Helio S Sader; Ronald Jones
Antimicrobial activity of ceftobiprole, a novel anti-methicillin-resistant Staphylococcus aureus cephalosporin, tested against contemporary pathogens: results from the SENTRY Antimicrobial Surveillance Program (2005-2006).
Diagnostic microbiology and infectious disease 2008;61(1):86-95.
2008: Thomas R Fritsche; Paul R Rhomberg; Helio S Sader; Ronald Jones
Antimicrobial activity of omiganan pentahydrochloride tested against contemporary bacterial pathogens commonly responsible for catheter-associated infections.
The Journal of antimicrobial chemotherapy 2008;61(5):1092-8.
2008: Rodrigo E Mendes; Thomas R Fritsche; Helio S Sader; Ronald Jones
Increased antimicrobial susceptibility profiles among polymyxin-resistant Acinetobacter baumannii clinical isolates.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008;46(8):1324-6.
2008: Mariana Castanheira; Thomas R Fritsche; Helio S Sader; Ronald Jones
RmtD 16S RNA methylase in epidemiologically unrelated spm-1-producing Pseudomonas aeruginosa isolates from Brazil.
Antimicrobial agents and chemotherapy 2008;52(4):1587-8; author reply 1588.
2008: Thomas R Fritsche; Paul R Rhomberg; Helio S Sader; Ronald Jones
In vitro activity of omiganan pentahydrochloride tested against vancomycin-tolerant, -intermediate, and -resistant Staphylococcus aureus.
Diagnostic microbiology and infectious disease 2008;60(4):399-403.
2008: Ana Gales; Helio S Sader; Thomas R Fritsche
Tigecycline activity tested against 11808 bacterial pathogens recently collected from US medical centers.
Diagnostic microbiology and infectious disease 2008;60(4):421-7.
2008: Rodrigo E Mendes; Helio S Sader; Lalitagauri M Deshpande; Ronald Jones
Antimicrobial activity of tigecycline against community-acquired methicillin-resistant Staphylococcus aureus isolates recovered from North American medical centers.
Diagnostic microbiology and infectious disease 2008;60(4):433-6.
2008: Helio S Sader; Thomas R Fritsche; Ronald Jones
Antimicrobial activities of Ceftaroline and ME1036 tested against clinical strains of community-acquired methicillin-resistant Staphylococcus aureus.
Antimicrobial agents and chemotherapy 2008;52(3):1153-5.
2008: Thomas R Fritsche; Paul R Rhomberg; Helio S Sader; Ronald Jones
Antimicrobial activity of omiganan pentahydrochloride against contemporary fungal pathogens responsible for catheter-associated infections.
Antimicrobial agents and chemotherapy 2008;52(3):1187-9.
2008: A C Galles; Ronald Jones; Helio S Sader
Antimicrobial susceptibility profile of contemporary clinical strains of Stenotrophomonas maltophilia isolates: can moxifloxacin activity be predicted by levofloxacin MIC results?
Journal of chemotherapy (Florence, Italy) 2008;20(1):38-42.
2008: Helio S Sader; A A Watters; T R Fritsche; Ronald Jones
Activity of daptomycin and selected antimicrobial agents tested against Staphylococcus aureus from patients with bloodstream infections hospitalized in European medical centers.
Journal of chemotherapy (Florence, Italy) 2008;20(1):28-32.
2008: Judy N Chin; Ronald Jones; Helio S Sader; Paul B Savage; Michael J Rybak
Potential synergy activity of the novel ceragenin, CSA-13, against clinical isolates of Pseudomonas aeruginosa, including multidrug-resistant P. aeruginosa.
The Journal of antimicrobial chemotherapy 2008;61(2):365-70.
2008: Mariana Castanheira; Helio S Sader; Lalitagauri M Deshpande; Thomas R Fritsche; Ronald Jones
Antimicrobial activities of tigecycline and other broad-spectrum antimicrobials tested against serine carbapenemase- and metallo-beta-lactamase-producing Enterobacteriaceae: report from the SENTRY Antimicrobial Surveillance Program.
Antimicrobial agents and chemotherapy 2008;52(2):570-3.
2008: U Garza-Ramos; P Tinoco; J Silva-Sanchez; R Morfin-Otero; E Rodriguez-Noriega; G Leon-Garnica; Helio S Sader; Ronald Jones
Metallo-beta-lactamase IMP-18 is located in a class 1 integron (In96) in a clinical isolate of Pseudomonas aeruginosa from Mexico.
International journal of antimicrobial agents 2008;31(1):78-80.
2007: Ronald Jones; Helio S Sader; Thomas R Fritsche; Michael J Janechek
Selection of a surrogate beta-lactam testing agent for initial susceptibility testing of doripenem, a new carbapenem.
Diagnostic microbiology and infectious disease 2007;59(4):467-72.
2007: Helio S Sader; Rajiv Mallick; Andreas Kuznik; Thomas R Fritsche; Ronald Jones
Use of in vitro susceptibility and pathogen prevalence data to model the expected clinical success rates of tigecycline and other commonly used antimicrobials for empirical treatment of complicated skin and skin-structure infections.
International journal of antimicrobial agents 2007;30(6):514-20.
2007: Jana M Swenson; William B Brasso; Mary Jane Ferraro; Dwight J Hardy; Cynthia C Knapp; Linda McDougal; L Barth Reller; Helio S Sader; Dee Shortridge; Robert Skov; Melvin P Weinstein; Barbara L Zimmer; Jean B Patel
Detection of inducible clindamycin resistance in staphylococci by broth microdilution using erythromycin-clindamycin combination wells.
Journal of clinical microbiology 2007;45(12):3954-7.
2007: Marta Tato; Teresa M Coque; P Ruíz-Garbajosa; Vicente Pintado; Javier Cobo; Helio S Sader; Ronald Jones; Fernando Baquero; Rafael Cantón
Complex clonal and plasmid epidemiology in the first outbreak of Enterobacteriaceae infection involving VIM-1 metallo-beta-lactamase in Spain: toward endemicity?
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007;45(9):1171-8.
2007: Ronald Jones; Thomas R Fritsche; Helio S Sader; James E Ross
LEADER surveillance program results for 2006: an activity and spectrum analysis of linezolid using clinical isolates from the United States (50 medical centers).
Diagnostic microbiology and infectious disease 2007;59(3):309-17.
2007: Ronald Jones; Thomas R Fritsche; Helio S Sader; James E Ross
Zyvox Annual Appraisal of Potency and Spectrum Program Results for 2006: an activity and spectrum analysis of linezolid using clinical isolates from 16 countries.
Diagnostic microbiology and infectious disease 2007;59(2):199-209.
2007: Douglas J Biedenbach; Jan M Bell; Helio S Sader; Thomas R Fritsche; Ronald Jones; John D Turnidge
Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004).
International journal of antimicrobial agents 2007;30(2):143-9.
2007: Rodrigo E Mendes; Mariana Castanheira; Mark Toleman; Helio S Sader; Ronald Jones; Timothy R Walsh
Characterization of an integron carrying blaIMP-1 and a new aminoglycoside resistance gene, aac(6')-31, and its dissemination among genetically unrelated clinical isolates in a Brazilian hospital.
Antimicrobial agents and chemotherapy 2007;51(7):2611-4.
2007: Daniel Curcio; Francisco Fernández; Ronald Jones; Mary Jane Ferraro; L Barth Reller; Paul C Schreckenberger; Helio S Sader
Tigecycline disk diffusion breakpoints of Acinetobacter spp.: a clinical point of view.
Journal of clinical microbiology 2007;45(6):2095; author reply 2095-6.
2007: Ronald Jones; Helio S Sader; Matthew G Stilwell; Thomas R Fritsche
Garenoxacin activity against isolates form patients hospitalized with community-acquired pneumonia and multidrug-resistant Streptococcus pneumoniae.
Diagnostic microbiology and infectious disease 2007;58(1):1-7.
2007: Ronald Jones; Thomas R Fritsche; Helio S Sader; Matthew G Stilwell
Activity of garenoxacin, an investigational des-F(6)-quinolone, tested against pathogens from community-acquired respiratory tract infections, including those with elevated or resistant-level fluoroquinolone MIC values.
Diagnostic microbiology and infectious disease 2007;58(1):9-17.
2007: Helio S Sader; Thomas R Fritsche; Ronald Jones
In vitro activity of garenoxacin tested against a worldwide collection of ciprofloxacin-susceptible and ciprofloxacin-resistant Enterobacteriaceae strains (1999-2004).
Diagnostic microbiology and infectious disease 2007;58(1):27-32.
2007: Thomas R Fritsche; Helio S Sader; Ronald Jones
Potency and spectrum of garenoxacin tested against an international collection of skin and soft tissue infection pathogens: report from the SENTRY antimicrobial surveillance program (1999-2004).
Diagnostic microbiology and infectious disease 2007;58(1):19-26.
2007: Helio S Sader; Mary Jane Ferraro; L Barth Reller; Paul C Schreckenberger; Jana M Swenson; Ronald Jones
Reevaluation of Clinical and Laboratory Standards Institute disk diffusion breakpoints for tetracyclines for testing Enterobacteriaceae.
Journal of clinical microbiology 2007;45(5):1640-3.
2007: Michael A Pfaller; Helio S Sader; Ronald Jones
Evaluation of the in vitro activity of daptomycin against 19615 clinical isolates of Gram-positive cocci collected in North American hospitals (2002-2005).
Diagnostic microbiology and infectious disease 2007;57(4):459-65.
2007: Helio S Sader; Michael R Jacobs; Thomas R Fritsche
Review of the spectrum and potency of orally administered cephalosporins and amoxicillin/clavulanate.
Diagnostic microbiology and infectious disease 2007;57(3 Suppl):5S-12S.
2007: James E Ross; Thomas R Fritsche; Helio S Sader; Ronald Jones
Oxazolidinone susceptibility patterns for 2005: International Report from the Zyvox Annual Appraisal of Potency and Spectrum Study.
International journal of antimicrobial agents 2007;29(3):295-301.
2007: Douglas J Biedenbach; James E Ross; Thomas R Fritsche; Helio S Sader; Ronald Jones
Activity of dalbavancin tested against Staphylococcus spp. and beta-hemolytic Streptococcus spp. isolated from 52 geographically diverse medical centers in the United States.
Journal of clinical microbiology 2007;45(3):998-1004.
2007: Helio S Sader; Andre Hsiung; Thomas R Fritsche; Ronald Jones
Comparative activities of cefepime and piperacillin/tazobactam tested against a global collection of Escherichia coli and Klebsiella spp. with an ESBL phenotype.
Diagnostic microbiology and infectious disease 2007;57(3):341-4.
2007: Sudha Pottumarthy; Helio S Sader; Ronald Jones
Bactericidal activity of cefepime and ceftriaxone tested against Streptococcus pneumoniae.
Diagnostic microbiology and infectious disease 2007;57(3):345-9.
2007: Andrea S Pereira; Soraya S Andrade; Jussimara Monteiro; Helio S Sader; A C C Pignatari; Ana Gales
Evaluation of the susceptibility profiles, genetic similarity and presence of qnr gene in Escherichia coli resistant to ciprofloxacin isolated in Brazilian hospitals.
The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases 2007;11(1):40-3.
2007: Helio S Sader; Sujata M Bhavnani; Paul G Ambrose; RN Jones; Michael A Pfaller
Re-evaluation of the role of broad-spectrum cephalosporins against staphylococci by applying contemporary in-vitro results and pharmacokinetic-pharmacodynamic principles.
Journal of chemotherapy (Florence, Italy) 2007;19(1):38-43.
2007: Helio S Sader; Ronald Jones
Cefdinir: an oral cephalosporin for the treatment of respiratory tract infections and skin and skin structure infections.
Expert review of anti-infective therapy 2007;5(1):29-43.
2007: H Aboufaycal; Helio S Sader; Kenneth Rolston; L M Deshpande; Mark Toleman; Gerald P Bodey; Issam Raad; Ronald Jones
blaVIM-2 and blaVIM-7 carbapenemase-producing Pseudomonas aeruginosa isolates detected in a tertiary care medical center in the United States: report from the MYSTIC program.
Journal of clinical microbiology 2007;45(2):614-5.
2007: Mariana Castanheira; Helio S Sader; Ronald Jones; Eugenio Debbia; Renata Cristina Picao; Ana Gales
In71, an Enterobacter cloacae blaVIM-1-carrying integron related to In70.2 from Italian Pseudomonas aeruginosa isolates: a SENTRY Antimicrobial Surveillance Program report.
Microbial drug resistance (Larchmont, N.Y.) 2007;13(2):130-4.
2007: Helio S Sader; Amy A Watters; Thomas R Fritsche; Ronald Jones
Daptomycin antimicrobial activity tested against methicillin-resistant staphylococci and vancomycin-resistant enterococci isolated in European medical centers (2005).
BMC infectious diseases 2007;7():29.
2007: Ronald Jones; Mary Jane Ferraro; L Barth Reller; Paul C Schreckenberger; Jana M Swenson; Helio S Sader
Multicenter studies of tigecycline disk diffusion susceptibility results for Acinetobacter spp.
Journal of clinical microbiology 2007;45(1):227-30.
2007: Ronald Jones; Helio S Sader; Thomas R Fritsche; Sudha Pottumarthy
Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
Diagnostic microbiology and infectious disease 2007;57(1):109-16.
2006: Lalitagauri M Deshpande; Ronald Jones; Thomas R Fritsche; Helio S Sader
Occurrence of plasmidic AmpC type beta-lactamase-mediated resistance in Escherichia coli: report from the SENTRY Antimicrobial Surveillance Program (North America, 2004).
International journal of antimicrobial agents 2006;28(6):578-81.
2006: Lalitagauri M Deshpande; Paul R Rhomberg; Helio S Sader; Ronald Jones
Emergence of serine carbapenemases (KPC and SME) among clinical strains of Enterobacteriaceae isolated in the United States Medical Centers: report from the MYSTIC Program (1999-2005).
Diagnostic microbiology and infectious disease 2006;56(4):367-72.
2006: Soraya S Andrade; Helio S Sader; Ronald Jones; Andrea S Pereira; A C C Pignatari; Ana Gales
Increased resistance to first-line agents among bacterial pathogens isolated from urinary tract infections in Latin America: time for local guidelines?
Memórias do Instituto Oswaldo Cruz 2006;101(7):741-8.
2006: Julival Ribeiro; Rodrigo E Mendes; R Domingos; E França; Suzane Silbert; Ronald Jones; Helio S Sader
Microbiological and epidemiological characterization of imipenem-resistant Pseudomonas aeruginosa strains from a Brazilian tertiary hospital: report from the SENTRY Antimicrobial Surveillance Program.
Journal of chemotherapy (Florence, Italy) 2006;18(5):461-7.
2006: Lalitagauri M Deshpande; Helio S Sader; Thomas R Fritsche; Ronald Jones
Contemporary prevalence of BRO beta-lactamases in Moraxella catarrhalis: report from the SENTRY antimicrobial surveillance program (North America, 1997 to 2004).
Journal of clinical microbiology 2006;44(10):3775-7.
2006: Helio S Sader; Ronald Jones
The activity of daptomycin against wild-type Staphylococcus aureus and strains with reduced susceptibility to vancomycin.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2006;43(6):798-9; author reply 799-800.
2006: Helio S Sader; J M Streit; Thomas R Fritsche; Ronald Jones
Antimicrobial susceptibility of gram-positive bacteria isolated from European medical centres: results of the Daptomycin Surveillance Programme (2002-2004).
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2006;12(9):844-52.
2006: Michael A Pfaller; Helio S Sader; Thomas R Fritsche; Ronald Jones
Antimicrobial activity of cefepime tested against ceftazidime-resistant Gram-negative clinical strains from North American Hospitals: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
Diagnostic microbiology and infectious disease 2006;56(1):63-8.
2006: Paul R Rhomberg; Thomas R Fritsche; Helio S Sader; Ronald Jones
Antimicrobial susceptibility pattern comparisons among intensive care unit and general ward Gram-negative isolates from the Meropenem Yearly Susceptibility Test Information Collection Program (USA).
Diagnostic microbiology and infectious disease 2006;56(1):57-62.
2006: Paul Mariani; Helio S Sader; Ronald Jones
Development of decreased susceptibility to daptomycin and vancomycin in a Staphylococcus aureus strain during prolonged therapy.
The Journal of antimicrobial chemotherapy 2006;58(2):481-3.
2006: Ronald Jones; Helio S Sader
Update on the cefdinir spectrum and potency against pathogens isolated from uncomplicated skin and soft tissue infections in North America: are we evaluating the orally administered cephalosporins correctly?
Diagnostic microbiology and infectious disease 2006;55(4):351-6.
2006: Ronald Jones; Helio S Sader; Thomas R Fritsche; Patricia A Hogan; Daniel J Sheehan
Selection of a surrogate agent (vancomycin or teicoplanin) for initial susceptibility testing of dalbavancin: results from an international antimicrobial surveillance program.
Journal of clinical microbiology 2006;44(7):2622-5.
2006: Maria C B Tognim; Ana Gales; Andréia P Penteado; Suzane Silbert; Helio S Sader
Dissemination of IMP-1 metallo- beta -lactamase-producing Acinetobacter species in a Brazilian teaching hospital.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 2006;27(7):742-7.
2006: Ronald Jones; Thomas R Fritsche; Helio S Sader; James E Ross
Activity of retapamulin (SB-275833), a novel pleuromutilin, against selected resistant gram-positive cocci.
Antimicrobial agents and chemotherapy 2006;50(7):2583-6.
2006: Helio S Sader; Thomas R Fritsche; Ronald Jones
Daptomycin bactericidal activity and correlation between disk and broth microdilution method results in testing of Staphylococcus aureus strains with decreased susceptibility to vancomycin.
Antimicrobial agents and chemotherapy 2006;50(7):2330-6.
2006: David M Johnson; Thomas R Fritsche; Helio S Sader; Ronald Jones
Evaluation of dalbavancin in combination with nine antimicrobial agents to detect enhanced or antagonistic interactions.
International journal of antimicrobial agents 2006;27(6):557-60.
2006: Kelley A Fedler; Ronald Jones; Helio S Sader; Thomas R Fritsche
Activity of gatifloxacin tested against isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (North America, 1998-2003).
Diagnostic microbiology and infectious disease 2006;55(2):157-64.
2006: Amy A Watters; Ronald Jones; Jennifer A Leeds; Gerald Denys; Helio S Sader; Thomas R Fritsche
Antimicrobial activity of a novel peptide deformylase inhibitor, LBM415, tested against respiratory tract and cutaneous infection pathogens: a global surveillance report (2003-2004).
The Journal of antimicrobial chemotherapy 2006;57(5):914-23.
2006: Ana Gales; Helio S Sader; Soraya S Andrade; Larissa Lutz; Adão Machado; Afonso L Barth
Emergence of linezolid-resistant Staphylococcus aureus during treatment of pulmonary infection in a patient with cystic fibrosis.
International journal of antimicrobial agents 2006;27(4):300-2.
2006: Ana Gales; Ronald Jones; Helio S Sader
Global assessment of the antimicrobial activity of polymyxin B against 54 731 clinical isolates of Gram-negative bacilli: report from the SENTRY antimicrobial surveillance programme (2001-2004).
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2006;12(4):315-21.
2006: Paul R Rhomberg; Thomas R Fritsche; Helio S Sader; Ronald Jones
Clonal occurrences of multidrug-resistant Gram-negative bacilli: report from the Meropenem Yearly Susceptibility Test Information Collection Surveillance Program in the United States (2004).
Diagnostic microbiology and infectious disease 2006;54(4):249-57.
2006: Helio S Sader; Thomas R Fritsche; Ronald Jones
Accuracy of three automated systems (MicroScan WalkAway, VITEK, and VITEK 2) for susceptibility testing of Pseudomonas aeruginosa against five broad-spectrum beta-lactam agents.
Journal of clinical microbiology 2006;44(3):1101-4.
2006: Lalitagauri M Deshpande; Helio S Sader; Eugenio Debbia; Giuseppe Nicoletti; Giovanni Fadda; Ronald Jones
Emergence and epidemiology of fluoroquinolone-resistant Streptococcus pneumoniae strains from Italy: report from the SENTRY Antimicrobial Surveillance Program (2001-2004).
Diagnostic microbiology and infectious disease 2006;54(3):157-64.
2006: Ronald Jones; Matthew G Stilwell; Helio S Sader; Thomas R Fritsche; Beth P Goldstein
Spectrum and potency of dalbavancin tested against 3322 Gram-positive cocci isolated in the United States Surveillance Program (2004).
Diagnostic microbiology and infectious disease 2006;54(2):149-53.
2006: Ronald Jones; James E Ross; Thomas R Fritsche; Helio S Sader
Oxazolidinone susceptibility patterns in 2004: report from the Zyvox Annual Appraisal of Potency and Spectrum (ZAAPS) Program assessing isolates from 16 nations.
The Journal of antimicrobial chemotherapy 2006;57(2):279-87.
2006: Lalitagauri M Deshpande; Ronald Jones; Thomas R Fritsche; Helio S Sader
Occurrence and characterization of carbapenemase-producing Enterobacteriaceae: report from the SENTRY Antimicrobial Surveillance Program (2000-2004).
Microbial drug resistance (Larchmont, N.Y.) 2006;12(4):223-30.
2006: Maria Cecília S Freitas; Alvaro Pacheco-Silva; Dulce Barbosa; Suzane Silbert; Helio S Sader; Ricardo Sesso; Luis Fernando A Camargo
Prevalence of vancomycin-resistant Enterococcus fecal colonization among kidney transplant patients.
BMC infectious diseases 2006;6():133.
2006: Mariana Castanheira; Ana Gales; A C C Pignatari; Ronald Jones; Helio S Sader
Changing antimicrobial susceptibility patterns among Streptococcus pneumoniae and Haemophilus influenzae from Brazil: Report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
Microbial drug resistance (Larchmont, N.Y.) 2006;12(2):91-8.
2006: A R Marra; C A P Pereira; Adauto Castelo; J R do Carmo Filho; R G R Cal; Helio S Sader; Sérgio Barsanti Wey
Health and economic outcomes of the detection of Klebsiella pneumoniae-produced extended-spectrum beta-lactamase (ESBL) in a hospital with high prevalence of this infection.
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2006;10(1):56-60.
2006: Ronald Jones; Helio S Sader; Thomas R Fritsche; Paul R Rhomberg
Carbapenem susceptibility discords among Acinetobacter isolates.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2006;42(1):158.
2005: Helio S Sader; P R Rhomberg; Ronald Jones
In vitro activity of beta-lactam antimicrobial agents in combination with aztreonam tested against metallo-beta-lactamase-producing Pseudomonas aeruginosa and Acinetobacter baumannii.
Journal of chemotherapy (Florence, Italy) 2005;17(6):622-7.
2005: Ronald Jones; Thomas R Fritsche; Helio S Sader; Beth P Goldstein
Antimicrobial spectrum and potency of dalbavancin tested against clinical isolates from Europe and North America (2003): initial results from an international surveillance protocol.
Journal of chemotherapy (Florence, Italy) 2005;17(6):593-600.
2005: Helio S Sader; Thomas R Fritsche; Ronald Jones
Antimicrobial activity of daptomycin tested against clinical strains of indicated species isolated in North American medical centers (2003).
Diagnostic microbiology and infectious disease 2005;53(4):329-32.
2005: Ronald Jones; Thomas R Fritsche; Yigong Ge; Koné Kaniga; Helio S Sader
Evaluation of PPI-0903M (T91825), a novel cephalosporin: bactericidal activity, effects of modifying in vitro testing parameters and optimization of disc diffusion tests.
The Journal of antimicrobial chemotherapy 2005;56(6):1047-52.
2005: Jennifer M Streit; Helio S Sader; Thomas R Fritsche; Ronald Jones
Dalbavancin activity against selected populations of antimicrobial-resistant Gram-positive pathogens.
Diagnostic microbiology and infectious disease 2005;53(4):307-10.
2005: Sudha Pottumarthy; Helio S Sader; Thomas R Fritsche; Ronald Jones
Susceptibility patterns for amoxicillin/clavulanate tests mimicking the licensed formulations and pharmacokinetic relationships: do the MIC obtained with 2:1 ratio testing accurately reflect activity against beta-lactamase-producing strains of Haemophilus influenzae and Moraxella catarrhalis?
Diagnostic microbiology and infectious disease 2005;53(3):225-31.
2005: Ana Gales; Ronald Jones; Soraya S Andrade; Andrea S Pereira; Helio S Sader
In vitro activity of tigecycline, a new glycylcycline, tested against 1,326 clinical bacterial strains isolated from Latin America.
The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases 2005;9(5):348-56.
2005: Helio S Sader; T R Fritsche; J M Streit; RN Jones
Daptomycin in vitro activity tested against Gram-positive strains collected from European and Latin American medical centers in 2003.
Journal of chemotherapy (Florence, Italy) 2005;17(5):477-83.
2005: P R Rhomberg; T R Fritsche; Helio S Sader; RN Jones
Comparative antimicrobial potency of meropenem tested against Gram-negative bacilli: report from the MYSTIC surveillance program in the United States (2004).
Journal of chemotherapy (Florence, Italy) 2005;17(5):459-69.
2005: Ana Gales; Ronald Jones; Soraya S Andrade; Helio S Sader
Antimicrobial susceptibility patterns of unusual nonfermentative gram-negative bacilli isolated from Latin America: report from the SENTRY Antimicrobial Surveillance Program (1997-2002).
Memórias do Instituto Oswaldo Cruz 2005;100(6):571-7.
2005: Sudha Pottumarthy; Yunson Yu; Helio S Sader; Ronald Jones; Minjun Chen
Susceptibility testing accuracy of a CTX-M-type extended-spectrum beta-lactamase organism-producing population of Enterobacteriaceae: intermethod analysis for 9 beta-lactams.
Diagnostic microbiology and infectious disease 2005;53(2):131-41.
2005: Thomas R Fritsche; Helio S Sader; Mark Toleman; Timothy R Walsh; Ronald Jones
Emerging metallo-beta-lactamase-mediated resistances: a summary report from the worldwide SENTRY antimicrobial surveillance program.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005;41 Suppl 4():S276-8.
2005: Helio S Sader; Thomas R Fritsche; Koné Kaniga; Yigong Ge; Ronald Jones
Antimicrobial activity and spectrum of PPI-0903M (T-91825), a novel cephalosporin, tested against a worldwide collection of clinical strains.
Antimicrobial agents and chemotherapy 2005;49(8):3501-12.
2005: Helio S Sader; Thomas R Fritsche; Ronald Jones
Potency and spectrum trends for cefepime tested against 65746 clinical bacterial isolates collected in North American medical centers: results from the SENTRY Antimicrobial Surveillance Program (1998-2003).
Diagnostic microbiology and infectious disease 2005;52(3):265-73.
2005: Thomas R Fritsche; Patty A Strabala; Helio S Sader; Michael J Dowzicky; Ronald Jones
Activity of tigecycline tested against a global collection of Enterobacteriaceae, including tetracycline-resistant isolates.
Diagnostic microbiology and infectious disease 2005;52(3):209-13.
2005: Helio S Sader; Ronald Jones; Michael J Dowzicky; Thomas R Fritsche
Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unit.
Diagnostic microbiology and infectious disease 2005;52(3):203-8.
2005: Thomas R Fritsche; Helio S Sader; Matthew G Stilwell; Michael J Dowzicky; Ronald Jones
Potency and spectrum of tigecycline tested against an international collection of bacterial pathogens associated with skin and soft tissue infections (2000-2004).
Diagnostic microbiology and infectious disease 2005;52(3):195-201.
2005: Thomas R Fritsche; Helio S Sader; Matthew G Stilwell; Michael J Dowzicky; Ronald Jones
Antimicrobial activity of tigecycline tested against organisms causing community-acquired respiratory tract infection and nosocomial pneumonia.
Diagnostic microbiology and infectious disease 2005;52(3):187-93.
2005: Helio S Sader; Ronald Jones; Matthew G Stilwell; Michael J Dowzicky; Thomas R Fritsche
Tigecycline activity tested against 26,474 bloodstream infection isolates: a collection from 6 continents.
Diagnostic microbiology and infectious disease 2005;52(3):181-6.
2005: Tamara R Anderegg; Helio S Sader; Thomas R Fritsche; James E Ross; Ronald Jones
Trends in linezolid susceptibility patterns: report from the 2002-2003 worldwide Zyvox Annual Appraisal of Potency and Spectrum (ZAAPS) Program.
International journal of antimicrobial agents 2005;26(1):13-21.
2005: Ronald Jones; Thomas R Fritsche; Helio S Sader
Therapeutic options among broad-spectrum beta-lactams for infections caused by levofloxacin-nonsusceptible Streptococcus pneumoniae.
Diagnostic microbiology and infectious disease 2005;52(2):129-33.
2005: Sudha Pottumarthy; Lalitagauri M Deshpande; Helio S Sader; Ronald Jones
Reevaluation of the cefepime minimal inhibitory concentrations and disk diffusion test zone diameter relationship for a worldwide collection of Enterobacteriaceae enriched for extended-spectrum beta-lactamase-producing organisms.
Diagnostic microbiology and infectious disease 2005;52(2):95-9.
2005: Ronald Jones; Helio S Sader; Thomas R Fritsche
Comparative activity of doripenem and three other carbapenems tested against Gram-negative bacilli with various beta-lactamase resistance mechanisms.
Diagnostic microbiology and infectious disease 2005;52(1):71-4.
2005: James E Ross; Tamara R Anderegg; Helio S Sader; Thomas R Fritsche; Ronald Jones
Trends in linezolid susceptibility patterns in 2002: report from the worldwide Zyvox Annual Appraisal of Potency and Spectrum Program.
Diagnostic microbiology and infectious disease 2005;52(1):53-8.
2005: Helio S Sader; Ronald Jones
Comprehensive in vitro evaluation of cefepime combined with aztreonam or ampicillin/sulbactam against multi-drug resistant Pseudomonas aeruginosa and Acinetobacter spp.
International journal of antimicrobial agents 2005;25(5):380-4.
2005: Thomas R Fritsche; Helio S Sader; Roy Cleeland; Ronald Jones
Comparative antimicrobial characterization of LBM415 (NVP PDF-713), a new peptide deformylase inhibitor of clinical importance.
Antimicrobial agents and chemotherapy 2005;49(4):1468-76.
2005: Sudha Pottumarthy; Thomas R Fritsche; Helio S Sader; Matthew G Stilwell; Ronald Jones
Susceptibility patterns of Streptococcus pneumoniae isolates in North America (2002-2003): contemporary in vitro activities of amoxicillin/clavulanate and 15 other antimicrobial agents.
International journal of antimicrobial agents 2005;25(4):282-9.
2005: James E Ross; Helio S Sader; Thomas R Fritsche; Ronald Jones
Reproducibility of gemifloxacin and comparison fluoroquinolone MIC results using Sensititre commercial dry-form panels.
Diagnostic microbiology and infectious disease 2005;51(3):219-21.
2005: Paul R Rhomberg; Helio S Sader; Ronald Jones
Reproducibility of daptomycin MIC results using dry-form commercial trays with appropriate supplemental calcium content.
International journal of antimicrobial agents 2005;25(3):274-6.
2005: Ronald Jones; Helio S Sader; Thomas R Fritsche
Antimicrobial activity of LBM415 (NVP PDF-713) tested against pathogenic Neisseria spp. (Neisseria gonorrhoeae and Neisseria meningitidis).
Diagnostic microbiology and infectious disease 2005;51(2):139-41.
2005: Ronald Jones; Douglas J Biedenbach; Helio S Sader; Thomas R Fritsche; Mark Toleman; Timothy R Walsh
Emerging epidemic of metallo-beta-lactamase-mediated resistances.
Diagnostic microbiology and infectious disease 2005;51(2):77-84.
2005: Ana Gales; Helio S Sader; Ronald Jones
Antimicrobial activity of dalbavancin tested against Gram-positive clinical isolates from Latin American medical centres.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2005;11(2):95-100.
2005: Helio S Sader; Ronald Jones
Antimicrobial susceptibility of uncommonly isolated non-enteric Gram-negative bacilli.
International journal of antimicrobial agents 2005;25(2):95-109.
2005: Helio S Sader; Adriana O Reis; Suzane Silbert; Ana Gales
IMPs, VIMs and SPMs: the diversity of metallo-beta-lactamases produced by carbapenem-resistant Pseudomonas aeruginosa in a Brazilian hospital.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2005;11(1):73-6.
2005: Helio S Sader; Douglas J Biedenbach; Jennifer M Streit; Ronald Jones
Cefdinir activity against contemporary North American isolates from community-acquired urinary tract infections.
International journal of antimicrobial agents 2005;25(1):89-92.
2005: Helio S Sader; Mariana Castanheira; Rodrigo E Mendes; Mark Toleman; Timothy R Walsh; Ronald Jones
Dissemination and diversity of metallo-beta-lactamases in Latin America: report from the SENTRY Antimicrobial Surveillance Program.
International journal of antimicrobial agents 2005;25(1):57-61.
2004: Shawn A Messer; Jeffrey T Kirby; Helio S Sader; Thomas R Fritsche; Ronald Jones
Initial results from a longitudinal international surveillance programme for anidulafungin (2003).
The Journal of antimicrobial chemotherapy 2004;54(6):1051-6.
2004: Rodrigo E Mendes; Mark Toleman; Julival Ribeiro; Helio S Sader; Ronald Jones; Timothy R Walsh
Integron carrying a novel metallo-beta-lactamase gene, blaIMP-16, and a fused form of aminoglycoside-resistant gene aac(6')-30/aac(6')-Ib': report from the SENTRY Antimicrobial Surveillance Program.
Antimicrobial agents and chemotherapy 2004;48(12):4693-702.
2004: Helio S Sader; Jennifer M Streit; Thomas R Fritsche; Ronald Jones
Antimicrobial activity of daptomycin against multidrug-resistant Gram-positive strains collected worldwide.
Diagnostic microbiology and infectious disease 2004;50(3):201-4.
2004: Suzane Silbert; Michael A Pfaller; Richard J Hollis; Afonso L Barth; Helio S Sader
Evaluation of three molecular typing techniques for nonfermentative Gram-negative bacilli.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 2004;25(10):847-51.
2004: Wen-Liang Yu; Patricia L Winokur; Ronald Jones; Helio S Sader
Surveillance in Taiwan using molecular epidemiology for extended-spectrum beta-lactamase-producing Klebsiella pneumoniae.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 2004;25(10):812-8.
2004: Lalitagauri M Deshpande; Paul R Rhomberg; Thomas R Fritsche; Helio S Sader; Ronald Jones
Bactericidal activity of BAL9141, a novel parenteral cephalosporin against contemporary Gram-positive and Gram-negative isolates.
Diagnostic microbiology and infectious disease 2004;50(1):73-5.
2004: Maria C B Tognim; Soraya S Andrade; Suzane Silbert; Ana Gales; Ronald Jones; Helio S Sader
Resistance trends of Acinetobacter spp. in Latin America and characterization of international dissemination of multi-drug resistant strains: five-year report of the SENTRY Antimicrobial Surveillance Program.
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2004;8(5):284-91.
2004: Ana Gales; Soraya S Andrade; Helio S Sader; Ronald Jones
Activity of mupirocin and 14 additional antibiotics against staphylococci isolated from Latin American hospitals: report from the SENTRY antimicrobial surveillance program.
Journal of chemotherapy (Florence, Italy) 2004;16(4):323-8.
2004: Helio S Sader; Jennifer M Streit; Thomas R Fritsche; Ronald Jones
Potency and spectrum reevaluation of cefdinir tested against pathogens causing skin and soft tissue infections: a sample of North American isolates.
Diagnostic microbiology and infectious disease 2004;49(4):283-7.
2004: Paul R Rhomberg; Ronald Jones; Helio S Sader; Thomas R Fritsche
Antimicrobial resistance rates and clonality results from the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) programme: report of year five (2003).
Diagnostic microbiology and infectious disease 2004;49(4):273-81.
2004: Jennifer M Streit; Ronald Jones; Helio S Sader; Thomas R Fritsche
Assessment of pathogen occurrences and resistance profiles among infected patients in the intensive care unit: report from the SENTRY Antimicrobial Surveillance Program (North America, 2001).
International journal of antimicrobial agents 2004;24(2):111-8.
2004: Helio S Sader; Kelley A Fedler; Robert P Rennie; Shelley Stevens; Ronald Jones
Omiganan pentahydrochloride (MBI 226), a topical 12-amino-acid cationic peptide: spectrum of antimicrobial activity and measurements of bactericidal activity.
Antimicrobial agents and chemotherapy 2004;48(8):3112-8.
2004: Dulce Barbosa; Lidimara Lima; Suzane Silbert; Helio S Sader; Miguel Cendoroglo; Sergio A Draibe; Luis Camargo; Lucila Vianna; Angelica Belasco; Ricardo Sesso
Evaluation of the prevalence and risk factors for colonization by vancomycin-resistant Enterococcus among patients on dialysis.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2004;44(2):337-43.
2004: Ronald Jones; Lalitagauri M Deshpande; Thomas R Fritsche; Helio S Sader
Determination of epidemic clonality among multidrug-resistant strains of Acinetobacter spp. and Pseudomonas aeruginosa in the MYSTIC Programme (USA, 1999-2003).
Diagnostic microbiology and infectious disease 2004;49(3):211-6.
2004: T R Anderegg; Ronald Jones; Helio S Sader
Quality control guidelines for BAL9141 (Ro 63-9141), an investigational cephalosporin, when reference MIC and standardized disk diffusion susceptibility test methods are used.
Journal of clinical microbiology 2004;42(7):3356-8.
2004: Mariana Castanheira; Ana Gales; Rodrigo E Mendes; Ronald Jones; Helio S Sader
Antimicrobial susceptibility of Streptococcus pneumoniae in Latin America: results from five years of the SENTRY Antimicrobial Surveillance Program.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2004;10(7):645-51.
2004: Ronald Jones; Holly K Huynh; Douglas J Biedenbach; Thomas R Fritsche; Helio S Sader
Doripenem (S-4661), a novel carbapenem: comparative activity against contemporary pathogens including bactericidal action and preliminary in vitro methods evaluations.
The Journal of antimicrobial chemotherapy 2004;54(1):144-54.
2004: Caio Mendes; Carlos R V Kiffer; Renée S Blosser-Middleton; Mark E Jones; James A Karlowsky; A Barth; F Rossi; S Andrade; Helio S Sader; Clyde Thornsberry; Daniel F Sahm
Antimicrobial susceptibility to levofloxacin and other antibacterial agents among common respiratory pathogens-a Brazilian perspective from the GLOBAL Surveillance Initiative 2001-2002.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2004;10(6):521-6.
2004: Ronald Jones; Helio S Sader; Thomas R Fritsche
Doxycycline use for community-acquired pneumonia: contemporary in vitro spectrum of activity against Streptococcus pneumoniae (1999-2002).
Diagnostic microbiology and infectious disease 2004;49(2):147-9.
2004: Ronald Jones; Thomas R Fritsche; Helio S Sader
Antimicrobial spectrum and activity of NVP PDF-713, a novel peptide deformylase inhibitor, tested against 1,837 recent Gram-positive clinical isolates.
Diagnostic microbiology and infectious disease 2004;49(1):63-5.
2004: Ronald Jones; Gary J Moet; Helio S Sader; Thomas R Fritsche
Potential utility of a peptide deformylase inhibitor (NVP PDF-713) against oxazolidinone-resistant or streptogramin-resistant Gram-positive organism isolates.
The Journal of antimicrobial chemotherapy 2004;53(5):804-7.
2004: Jennifer M Streit; Ronald Jones; Helio S Sader
Daptomycin activity and spectrum: a worldwide sample of 6737 clinical Gram-positive organisms.
The Journal of antimicrobial chemotherapy 2004;53(4):669-74.
2004: Ivana Barbosa Suffredini; Helio S Sader; A G Gonçalves; Adriana O Reis; Ana Gales; Antonio Drauzio Varella; Ronald Joseph Younes
Screening of antibacterial extracts from plants native to the Brazilian Amazon Rain Forest and Atlantic Forest.
Brazilian journal of medical and biological research = Revista brasileira de pesquisas médicas e biológicas / Sociedade Brasileira de Biofísica ... [et al.] 2004;37(3):379-84.
2004: J C R Cordeiro; Suzane Silbert; Adriana O Reis; Helio S Sader
Inter-hospital dissemination of glycopeptide-resistant Enterococcus faecalis in Brazil.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2004;10(3):260-2.
2004: Helio S Sader; Ronald Jones; Ana Gales; Juliana B Silva; A C C Pignatari
SENTRY antimicrobial surveillance program report: Latin American and Brazilian results for 1997 through 2001.
The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases 2004;8(1):25-79.
2004: Jennifer M Streit; Thomas R Fritsche; Helio S Sader; Ronald Jones
Worldwide assessment of dalbavancin activity and spectrum against over 6,000 clinical isolates.
Diagnostic microbiology and infectious disease 2004;48(2):137-43.
2004: Alan H Mutnick; Paul R Rhomberg; Helio S Sader; Ronald Jones
Antimicrobial usage and resistance trend relationships from the MYSTIC Programme in North America (1999-2001).
The Journal of antimicrobial chemotherapy 2004;53(2):290-6.
2004: Ana Gales; Michael A Pfaller; Helio S Sader; Richard J Hollis; Ronald Jones
Genotypic characterization of carbapenem-nonsusceptible Acinetobacter spp. isolated in Latin America.
Microbial drug resistance (Larchmont, N.Y.) 2004;10(4):286-91.
2004: Paul R Rhomberg; Ronald Jones; Helio S Sader
Results from the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) Programme: report of the 2001 data from 15 United States medical centres.
International journal of antimicrobial agents 2004;23(1):52-9.
2004: Jeffrey T Kirby; Helio S Sader; Timothy R Walsh; Ronald Jones
Antimicrobial susceptibility and epidemiology of a worldwide collection of Chryseobacterium spp: report from the SENTRY Antimicrobial Surveillance Program (1997-2001).
Journal of clinical microbiology 2004;42(1):445-8.
2004: Helio S Sader; David M Johnson; Ronald Jones
In vitro activities of the novel cephalosporin LB 11058 against multidrug-resistant Staphylococci and Streptococci.
Antimicrobial agents and chemotherapy 2004;48(1):53-62.
2003: Ronald Jones; Helio S Sader; Mondell L Beach
Contemporary in vitro spectrum of activity summary for antimicrobial agents tested against 18569 strains non-fermentative Gram-negative bacilli isolated in the SENTRY Antimicrobial Surveillance Program (1997-2001).
International journal of antimicrobial agents 2003;22(6):551-6.
2003: Iraci Tosin; Suzane Silbert; Helio S Sader
The use of molecular typing to evaluate the dissemination of antimicrobial resistance among Gram-negative rods in Brazilian hospitals.
The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases 2003;7(6):360-9.
2003: Helio S Sader; Holly K Huynh; Ronald Jones
Contemporary in vitro synergy rates for aztreonam combined with newer fluoroquinolones and beta-lactams tested against gram-negative bacilli.
Diagnostic microbiology and infectious disease 2003;47(3):547-50.
2003: Helio S Sader; Thomas R Fritsche; Alan H Mutnick; Ronald Jones
Contemporary evaluation of the in vitro activity and spectrum of cefdinir compared with other orally administered antimicrobials tested against common respiratory tract pathogens (2000-2002).
Diagnostic microbiology and infectious disease 2003;47(3):515-25.
2003: Rodrigo E Mendes; Adriana O Reis; Ana Gales; Ronald Jones; Helio S Sader
Ability of Latin America laboratories to detect antimicrobial resistance patterns: experience of the SENTRY Antimicrobial Surveillance Program (1997-2000).
The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases 2003;7(5):282-9.
2003: Thomas R Fritsche; Helio S Sader; Ronald Jones
Comparative activity and spectrum of broad-spectrum beta-lactams (cefepime, ceftazidime, ceftriaxone, piperacillin/tazobactam) tested against 12,295 staphylococci and streptococci: report from the SENTRY antimicrobial surveillance program (North America: 2001-2002).
Diagnostic microbiology and infectious disease 2003;47(2):435-40.
2003: Ana Gales; Liana C Menezes; Suzane Silbert; Helio S Sader
Dissemination in distinct Brazilian regions of an epidemic carbapenem-resistant Pseudomonas aeruginosa producing SPM metallo-beta-lactamase.
The Journal of antimicrobial chemotherapy 2003;52(4):699-702.
2003: Kelley A Gordon; Helio S Sader; Ronald Jones
Contemporary re-evaluation of the activity and spectrum of grepafloxacin tested against isolates in the United States.
Diagnostic microbiology and infectious disease 2003;47(1):377-83.
2003: D M Johnson; Helio S Sader; Thomas R Fritsche; Douglas J Biedenbach; Ronald Jones
Susceptibility trends of haemophilus influenzae and Moraxella catarrhalis against orally administered antimicrobial agents: five-year report from the SENTRY Antimicrobial Surveillance Program.
Diagnostic microbiology and infectious disease 2003;47(1):373-6.
2003: Helio S Sader; Douglas J Biedenbach; Ronald Jones
Global patterns of susceptibility for 21 commonly utilized antimicrobial agents tested against 48,440 Enterobacteriaceae in the SENTRY Antimicrobial Surveillance Program (1997-2001).
Diagnostic microbiology and infectious disease 2003;47(1):361-4.
2003: Adriana O Reis; Deise A M Luz; Maria C B Tognim; Helio S Sader; Ana Gales
Polymyxin-resistant Acinetobacter spp. isolates: what is next?
Emerging infectious diseases 2003;9(8):1025-7.
2003: Soraya S Andrade; Ronald Jones; Ana Gales; Helio S Sader
Increasing prevalence of antimicrobial resistance among Pseudomonas aeruginosa isolates in Latin American medical centres: 5 year report of the SENTRY Antimicrobial Surveillance Program (1997-2001).
The Journal of antimicrobial chemotherapy 2003;52(1):140-1.
2003: Renato Satovschi Grinbaum; Thaís Guimarães; Elisa Kusano; Nair Hosino; Helio S Sader; Rosângela F Cereda
A pseudo-outbreak of vancomycin-resistant Enterococcus faecium.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 2003;24(6):461-4.
2003: Soraya Andrade-Baiocchi; Maria C B Tognim; OTAVIO BAIOCCHI; Helio S Sader
Endocarditis due to glycopeptide-intermediate Staphylococcus aureus: case report and strain characterization.
Diagnostic microbiology and infectious disease 2003;45(2):149-52.
2003: Mariana Castanheira; Ronald Jones; Suzane Silbert; Maria Cristina C Brandileone; Helio S Sader
Typing and molecular characterization of Streptococcus pneumoniae with reduced susceptibility to cefotaxime isolated in Latin America.
Microbial drug resistance (Larchmont, N.Y.) 2003;9(4):345-51.
2003: Ana Gales; Maria C B Tognim; Adriana O Reis; Ronald Jones; Helio S Sader
Emergence of an IMP-like metallo-enzyme in an Acinetobacter baumannii clinical strain from a Brazilian teaching hospital.
Diagnostic microbiology and infectious disease 2003;45(1):77-9.
2002: Carlos Bantar; L Bavestrello; Daniel Curcio; A Jasovich; Rubén Absi; Homero Bagnulo; Angela Famiglietti; Patricia García; Jaime Labarca; Jorge Mera; Walter Pedreira; Helio S Sader; Luis Thompson; Sergio Wey
Acute community-acquired pneumonia in adults: guidelines for initial antimicrobial therapy based on local evidence from a South American Working Group (ConsenSur).
Journal of chemotherapy (Florence, Italy) 2002;14 Suppl 4():1-22.
2002: H López; Helio S Sader; C Amábile; Walter Pedreira; Juan Luis Muñoz Bellido; José Angel García-Rodríguez
[In vitro activity of moxifloxacin against respiratory pathogens in Latin America].
Revista española de quimioterapia : publicación oficial de la Sociedad Española de Quimioterapia 2002;15(4):325-34.
2002: Carlos Bantar; L Bavestrello; Daniel Curcio; A Jasovich; Rubén Absi; Homero Bagnulo; Angela Famiglietti; Patricia García; Jaime Labarca; Jorge Mera; Walter Pedreira; Helio S Sader; Luis Thompson; Sergio Wey
Acute community-acquired pneumonia in adults: guidelines for initial antimicrobial therapy based on local evidence from a South American working group (ConsenSur).
Journal of chemotherapy (Florence, Italy) 2002;14(6):635-6.
2002: Ana Gales; Helio S Sader; Rodrigo E Mendes; Ronald Jones
Salmonella spp. isolates causing bloodstream infections in Latin America: report of antimicrobial activity from the SENTRY Antimicrobial Surveillance Program (1997-2000).
Diagnostic microbiology and infectious disease 2002;44(3):313-8.
2002: Ana Gales; Helio S Sader; Ronald Jones
Urinary tract infection trends in Latin American hospitals: report from the SENTRY antimicrobial surveillance program (1997-2000).
Diagnostic microbiology and infectious disease 2002;44(3):289-99.
2002: Helio S Sader; Ronald Jones; Juliana B Silva
Skin and soft tissue infections in Latin American medical centers: four-year assessment of the pathogen frequency and antimicrobial susceptibility patterns.
Diagnostic microbiology and infectious disease 2002;44(3):281-8.
2002: Helio S Sader; Ronald Jones; Soraya Andrade-Baiocchi; Douglas J Biedenbach
Four-year evaluation of frequency of occurrence and antimicrobial susceptibility patterns of bacteria from bloodstream infections in Latin American medical centers.
Diagnostic microbiology and infectious disease 2002;44(3):273-80.
2002: Clovis Arns da Cunha; Helio S Sader; Antonio C Nicodemo
Antimicrobial therapy for community-acquired pneumonia in adults.
The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases 2002;6(2):82-7.
2002: Rosangela F Cereda; Ana Gales; Suzane Silbert; Ronald Jones; Helio S Sader
Molecular typing and antimicrobial susceptibility of vancomycin-resistant Enterococcus faecium in Brazil.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 2002;23(1):19-22.
2001: Ian A Critchley; R S Blosser; James A Karlowsky; Juri Yamakita; A Barth; Helio S Sader; C Mendes; L Teixeira; F Rossi; C A Dias; Mark E Jones; Clyde Thornsberry; Daniel F Sahm
Antimicrobial resistance in respiratory pathogens isolated in Brazil during 1999-2000.
The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases 2001;5(6):294-304.
2001: Suzane Silbert; Afonso L Barth; Helio S Sader
Heterogeneity of Pseudomonas aeruginosa in Brazilian cystic fibrosis patients.
Journal of clinical microbiology 2001;39(11):3976-81.
2001: Adriana O Reis; J C R Cordeiro; A M Machado; Helio S Sader
In vitro antimicrobial activity of linezolid tested against vancomycin-resistant enterococci isolated in Brazilian hospitals.
The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases 2001;5(5):243-51.
2001: Michael A Pfaller; D J Diekema; Ronald Jones; Helio S Sader; A C Fluit; Richard J Hollis; S A Messer
International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surveillance program.
Journal of clinical microbiology 2001;39(9):3254-9.
2001: Helio S Sader; Ana Gales; Michael A Pfaller; Rodrigo E Mendes; C Zoccoli; A Barth; Ronald Jones
Pathogen frequency and resistance patterns in Brazilian hospitals: summary of results from three years of the SENTRY Antimicrobial Surveillance Program.
The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases 2001;5(4):200-14.
2001: Helio S Sader; Ana Gales; Ronald Jones
Antimicrobial activity of linezolid against Gram-positive cocci isolated in Brazil.
The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases 2001;5(4):171-6.
2001: J C R Cordeiro; Adriana O Reis; E A Miranda; Helio S Sader
In vitro antimicrobial activity of the aminoglycoside arbekacin tested against oxacillin-resistant Staphylococcus aureus isolated in Brazilian hospitals.
The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases 2001;5(3):130-5.
2001: Michael A Pfaller; J Acar; Ronald Jones; Jan Verhoef; J Turnidge; Helio S Sader
Integration of molecular characterization of microorganisms in a global antimicrobial resistance surveillance program.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2001;32 Suppl 2():S156-67.
2001: Ana Gales; Ronald Jones; K R Forward; J Liñares; Helio S Sader; Jan Verhoef
Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY Antimicrobial Surveillance Program (1997-1999).
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2001;32 Suppl 2():S104-13.
2001: Ana Gales; Helio S Sader; Ronald Jones
Activities of BMS 284756 (T-3811) against Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae isolates from SENTRY antimicrobial surveillance program medical centers in Latin America (1999).
Antimicrobial agents and chemotherapy 2001;45(5):1463-6.
2001: Rosângela F Cereda; Helio S Sader; L Sejas; A Machado; Y Zanatta; S Rego; E Medeiros
Enterococcus faecalis resistant to vancomycin and teicoplanin (VanA phenotype) isolated from a bone marrow transplanted patient in Brazil.
The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases 2001;5(1):40-6.
2001: Helio S Sader; Ronald Jones; C H Ballow; D J Biedenbach; R F Cered
Antimicrobial susceptibility of quinupristin/dalfopristin tested against gram-positive cocci from Latin America: results from the global SMART (GSMART) surveillance study.
The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases 2001;5(1):21-31.
2001: Helio S Sader; Ana Gales
Emerging strategies in infectious diseases: new carbapenem and trinem antibacterial agents.
Drugs 2001;61(5):553-64.
2000: Helio S Sader; L Del'Alamo
Etest compared to broth microdilution: discrepant results when testing macrolides against Streptococcus pneumoniae indicate a need for better clinical and serum level/MIC correlation.
The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases 2000;4(5):268-70.
2000: Helio S Sader; Ana Gales; T D Granacher; Michael A Pfaller; Ronald Jones
Prevalence of antimicrobial resistance among respiratory tract isolates in Latin America: results from SENTRY antimicrobial surveillance program (1997-98).
The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases 2000;4(5):245-54.
2000: R K Roland; Rodrigo E Mendes; Suzane Silbert; A P Bolsoni; Helio S Sader
In vitro antimicrobial activity of piperacillin/tazobactam in comparison with other broad-spectrum beta-lactams.
The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases 2000;4(5):226-35.
2000: MT Lewis; Ana Gales; Helio S Sader; Michael A Pfaller; Ronald Jones
Frequency of occurrence and antimicrobial susceptibility patterns for pathogens isolated from latin american patients with a diagnosis of pneumonia: results from the SENTRY antimicrobial surveillance program (1998).
Diagnostic microbiology and infectious disease 2000;37(1):63-74.
2000: Ian A Critchley; Clyde Thornsberry; G Piazza; M Jones; ML Hickey; A L Barth; C Mendes; F F Rossi; Helio S Sader; Lucia Martins Teixeira; Daniel F Sahm
Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis collected from five centers in Brazil, 1997-98.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2000;6(4):178-84.
2000: Helio S Sader
Antimicrobial resistance in Brazil: comparison of results from two multicenter studies.
The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases 2000;4(2):91-9.
2000: M Guzmán-Blanco; J M Casellas; Helio S Sader
Bacterial resistance to antimicrobial agents in Latin America. The giant is awakening.
Infectious disease clinics of North America 2000;14(1):67-81, viii.
2000: Ana Gales; Ronald Jones; Kelley A Gordon; Helio S Sader; Werner W Wilke; Mondell L Beach; Michael A Pfaller; G V Doern
Activity and spectrum of 22 antimicrobial agents tested against urinary tract infection pathogens in hospitalized patients in Latin America: report from the second year of the SENTRY antimicrobial surveillance program (1998).
The Journal of antimicrobial chemotherapy 2000;45(3):295-303.
2000: Michael A Pfaller; Ronald Jones; G V Doern; Helio S Sader; Shawn A Messer; AK Houston; Stacy Coffman; Richard J Hollis
Bloodstream infections due to Candida species: SENTRY antimicrobial surveillance program in North America and Latin America, 1997-1998.
Antimicrobial agents and chemotherapy 2000;44(3):747-51.
2000: Helio S Sader; I Tosin; L Sejas; E Miranda
Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam.
The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases 2000;4(1):22-8.
2000: Daniel J Diekema; Michael A Pfaller; Ronald Jones; G V Doern; KC Kugler; Mondell L Beach; Helio S Sader
Trends in antimicrobial susceptibility of bacterial pathogens isolated from patients with bloodstream infections in the USA, Canada and Latin America. SENTRY Participants Group.
International journal of antimicrobial agents 2000;13(4):257-71.
2000: Ana Gales; Ronald Jones; Michael A Pfaller; Kelley A Gordon; Helio S Sader
Two-year assessment of the pathogen frequency and antimicrobial resistance patterns among organisms isolated from skin and soft tissue infections in Latin American hospitals: results from the SENTRY antimicrobial surveillance program, 1997-98. SENTRY Study Group.
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2000;4(2):75-84.
1999: Daniel J Diekema; Michael A Pfaller; Ronald Jones; G V Doern; Patricia L Winokur; Ana Gales; Helio S Sader; KC Kugler; M Beach
Survey of bloodstream infections due to gram-negative bacilli: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, and Latin America for the SENTRY Antimicrobial Surveillance Program, 1997.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1999;29(3):595-607.
1999: Michael A Pfaller; Ronald Jones; G V Doern; A C Fluit; Jan Verhoef; Helio S Sader; Shawn A Messer; AK Houston; Stacy Coffman; Richard J Hollis
International surveillance of blood stream infections due to Candida species in the European SENTRY Program: species distribution and antifungal susceptibility including the investigational triazole and echinocandin agents. SENTRY Participant Group (Europe).
Diagnostic microbiology and infectious disease 1999;35(1):19-25.
1999: E A Arruda; IS Marinho; M Boulos; Sumiko Sinto; H H Caiaffa; Caio Mendes; Carmen P Oplustil; Helio S Sader; C E Levy; Anna S Levin
Nosocomial infections caused by multiresistant Pseudomonas aeruginosa.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 1999;20(9):620-3.
1999: L Del' Alamo; R F Cereda; I Tosin; E A Miranda; Helio S Sader
Antimicrobial susceptibility of coagulase-negative staphylococci and characterization of isolates with reduced susceptibility to glycopeptides.
Diagnostic microbiology and infectious disease 1999;34(3):185-91.
1999: Michael A Pfaller; Ronald Jones; G V Doern; Helio S Sader; KC Kugler; Mondell L Beach
Survey of blood stream infections attributable to gram-positive cocci: frequency of occurrence and antimicrobial susceptibility of isolates collected in 1997 in the United States, Canada, and Latin America from the SENTRY Antimicrobial Surveillance Program. SENTRY Participants Group.
Diagnostic microbiology and infectious disease 1999;33(4):283-97.
1998: Helio S Sader; Ronald Jones; Ana Gales; Patricia L Winokur; KC Kugler; Michael A Pfaller; G V Doern
Antimicrobial susceptibility patterns for pathogens isolated from patients in Latin American medical centers with a diagnosis of pneumonia: analysis of results from the SENTRY Antimicrobial Surveillance Program (1997). SENTRY Latin America Study Group.
Diagnostic microbiology and infectious disease 1998;32(4):289-301.
1998: Helio S Sader; Caio Mendes; A Montelli; J Sampaio; A J Segura; G L Kesselring; L Costa; J E Ribeiro; E Mamizuka; I Mimiça
[In vitro antimicrobial activity of cefpirome compared to other broad-spectrum beta-lactam drugs against 804 clinical isolates from 9 Brazilian hospitals].
Revista da Associação Médica Brasileira (1992) 1998;44(4):283-8.
1998: M E Jones; Ronald Jones; Helio S Sader; Jan Verhoef; J Acar
Current susceptibilities of staphylococci to glycopeptides determined as part of an international resistance surveillance programme. Sentry Antimicrobial Surveillance Program.
The Journal of antimicrobial chemotherapy 1998;42(1):119-21.
1998: Michael A Pfaller; Ronald Jones; G V Doern; Helio S Sader; Richard J Hollis; Shawn A Messer
International surveillance of bloodstream infections due to Candida species: frequency of occurrence and antifungal susceptibilities of isolates collected in 1997 in the United States, Canada, and South America for the SENTRY Program. The SENTRY Participant Group.
Journal of clinical microbiology 1998;36(7):1886-9.
1998: Ricardo Sesso; Dulce Barbosa; I L Leme; Helio S Sader; Maria Eugênia Fernandes Canziani; S Manfredi; Sergio A Draibe; A C C Pignatari
Staphylococcus aureus prophylaxis in hemodialysis patients using central venous catheter: effect of mupirocin ointment.
Journal of the American Society of Nephrology : JASN 1998;9(6):1085-92.
1997: I H Saraiva; Ronald Jones; M Erwin; Helio S Sader
[Evaluation of antimicrobial sensitivity of 87 clinical isolates of vancomycin-resistant enterococci].
Revista da Associação Médica Brasileira (1992) 1997;43(3):217-22.
1997: W V Farias; Helio S Sader; I L Leme; A C C Pignatari
[Sensitivity pattern of 117 clinical isolates of Staphylococcus aureus from 12 hospitals].
Revista da Associação Médica Brasileira (1992) 1997;43(3):199-204.
1997: Helio S Sader; I Mimiça; F Rossi; CM Zoccoli; A C Montelli; J L Sampaio; A J Segura; M Magalhães; A Nowakonski; Caio Mendes
Evaluation of the in vitro activity of cefepime compared to other broad-spectrum cephalosporins against clinical isolates from eighteen Brazilian hospitals by using the Etest.
Diagnostic microbiology and infectious disease 1997;28(2):87-92.
1997: Ana Gales; A C C Pignatari; Ronald Jones; M Baretta; Helio S Sader
[Evaluation of in vitro activity of new fluoroquinolones, cephalosporins and carbapenems against 569 gram-negative bacteria].
Revista da Associação Médica Brasileira (1992) 1997;43(2):137-44.
1996: Ana Gales; Helio S Sader; Sumiko Sinto; O P Santos; Caio Mendes
In vitro activity of ampicillin-sulbactam against clinical multiresistant Acinetobacter baumannii isolates.
Journal of chemotherapy (Florence, Italy) 1996;8(6):416-9.
1996: Helio S Sader; C F Mendes; A C C Pignatari; Michael A Pfaller
Use of macrorestriction analysis to demonstrate interhospital spread of multiresistant Acinetobacter baumannii in São Paulo, Brazil.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1996;23(3):631-4.
1996: I Mimica; Caio Mendes; L Mimica; C Oplustil; A C C Pignatari; Helio S Sader
[Study of the susceptibility of Staphylococcus sp. and Enterococcus sp. to teicoplanin and vancomycin].
Revista da Associação Médica Brasileira (1992) 1996;42(3):147-50.
1996: R F Cereda; A C C Pignatari; I L Leme; Ronald Jones; Helio S Sader
[In vitro susceptibility testing of 446 clinical isolates of gram-positive bacteria to new quinolones, carbapenems and cephalosporins].
Revista da Associação Médica Brasileira (1992) 1996;42(3):130-4.
1996: Anna S Levin; Caio Mendes; Sumiko Sinto; Helio S Sader; C R Scarpitta; E Rodrigues; N Sauaia; M Boulos
An outbreak of multiresistant Acinetobacter baumanii in a university hospital in São Paulo, Brazil.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 1996;17(6):366-8.
1995: Helio S Sader; Ronald Jones; Michael A Pfaller
Relapse of catheter-related Flavobacterium meningosepticum bacteremia demonstrated by DNA macrorestriction analysis.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1995;21(4):997-1000.
1995: Helio S Sader; Douglas J Biedenbach; Ronald Jones
Evaluation of Vitek and API 20S for species identification of enterococci.
Diagnostic microbiology and infectious disease 1995;22(4):315-9.
1995: Helio S Sader; Richard J Hollis; Michael A Pfaller
The use of molecular techniques in the epidemiology and control of infectious diseases.
Clinics in laboratory medicine 1995;15(2):407-31.
1995: Helio S Sader; Ronald Jones
[Cephalosporins: 4 generations of structural evolution].
Revista da Associação Médica Brasileira (1992) 1995;41(2):144-50.
1995: Ronald Jones; Helio S Sader; ME Erwin; S C Anderson
Emerging multiply resistant enterococci among clinical isolates. I. Prevalence data from 97 medical center surveillance study in the United States. Enterococcus Study Group.
Diagnostic microbiology and infectious disease 1995;21(2):85-93.
1995: Helio S Sader; Bruce A Runyon; ME Erwin; Ronald Jones
Antimicrobial activity of 11 newer and investigational drugs tested against aerobic isolates from spontaneous bacterial peritonitis.
Diagnostic microbiology and infectious disease 1995;21(2):105-10.
1994: Helio S Sader; Michael A Pfaller; Ronald Jones
Prevalence of important pathogens and the antimicrobial activity of parenteral drugs at numerous medical centers in the United States. II. Study of the intra- and interlaboratory dissemination of extended-spectrum beta-lactamase-producing Enterobacteriaceae.
Diagnostic microbiology and infectious disease 1994;20(4):203-8.
1994: Helio S Sader; Michael A Pfaller; Fred C Tenover; Richard J Hollis; Ronald Jones
Evaluation and characterization of multiresistant Enterococcus faecium from 12 U.S. medical centers.
Journal of clinical microbiology 1994;32(11):2840-2.
1994: Ronald Jones; Helio S Sader; ME Erwin
Update of lomefloxacin in vitro activity and spectrum. A multicenter trial testing contemporary pathogens following Food and Drug Administration validation guidelines. Lomefloxacin Activity Study Group.
Diagnostic microbiology and infectious disease 1994;20(2):93-8.
1994: Helio S Sader; A C C Pignatari
E test: a novel technique for antimicrobial susceptibility testing.
São Paulo medical journal = Revista paulista de medicina 1994;112(4):635-8.
1994: Helio S Sader; Ronald Jones
In vitro antimicrobial activity of cefpirome against ceftazidime-resistant isolates from two multicenter studies.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1994;13(8):675-9.
1994: Helio S Sader; Trish M Perl; Richard J Hollis; D Divishek; Loreen A Herwaldt; Ronald Jones
Nosocomial transmission of Serratia odorifera biogroup. 2: Case report demonstration by macrorestriction analysis of chromosomal DNA using pulsed-field gel electrophoresis.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 1994;15(6):390-3.
1994: Helio S Sader; A C C Pignatari; Richard J Hollis; Ronald Jones
Evaluation of interhospital spread of methicillin-resistant Staphylococcus aureus in Sao Paulo, Brazil, using pulsed-field gel electrophoresis of chromosomal DNA.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 1994;15(5):320-3.
1994: Helio S Sader; A C C Pignatari; R Frei; Richard J Hollis; Ronald Jones
Pulsed-field gel electrophoresis of restriction-digested genomic DNA and antimicrobial susceptibility of Xanthomonas maltophilia strains from Brazil, Switzerland and the USA.
The Journal of antimicrobial chemotherapy 1994;33(3):615-8.
1993: Helio S Sader; Ronald Jones; S D Allen; E H Gerlach; P R Murray; JA Washington
In vitro comparison activity of OPC-17116, a new fluoroquinolone, against more than 5,000 recent clinical isolates from five medical centers.
Journal of chemotherapy (Florence, Italy) 1993;5(5):283-8.
1993: Helio S Sader; Ronald Jones; JA Washington; P R Murray; E H Gerlach; S D Allen; ME Erwin
In vitro activity of cefpodoxime compared with other oral cephalosporins tested against 5556 recent clinical isolates from five medical centers.
Diagnostic microbiology and infectious disease 1993;17(2):143-50.
1993: Helio S Sader; A C C Pignatari; I L Leme; M N Burattini; R Tancresi; Richard J Hollis; Ronald Jones
Epidemiologic typing of multiply drug-resistant Pseudomonas aeruginosa isolated from an outbreak in an intensive care unit.
Diagnostic microbiology and infectious disease 1993;17(1):13-8.
1993: Helio S Sader; A C C Pignatari; Richard J Hollis; I Leme; Ronald Jones
Oxacillin- and quinolone-resistant Staphylococcus aureus in Sao Paulo, Brazil: a multicenter molecular epidemiology study.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 1993;14(5):260-4.
1993: Helio S Sader; Ronald Jones
Antimicrobial activity of the new carbapenem biapenem compared to imipenem, meropenem and other broad-spectrum beta-lactam drugs.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1993;12(5):384-91.
1992: Helio S Sader; Ronald Jones
Cefotaxime is extensively used for surgical prophylaxis.
American journal of surgery 1992;164(4A Suppl):28S-38S.
1992: Helio S Sader; ME Erwin; Ronald Jones
In vitro activity of OPC-17116 compared to other broad-spectrum fluoroquinolones.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1992;11(4):372-81.